NEW DELHIIndias government placed new price controls on more than  diabetes and heartdisease drugs broadening the scope of medicines subject to such limits in a move likely to pinch profits of international pharmaceutical companies in the worlds secondmostpopulous country The National Pharmaceutical Pricing Authority posted a notice on its website Friday that said large gaps in prices between brandname and generic versions of the same drug were indicative of a severe market failure It cited a regulation
  